Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.
about
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel diseaseDissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarraysDiversity of Intestinal Macrophages in Inflammatory Bowel DiseasesMechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont SelectionNanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseRole of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel diseaseNuclear factor kappa B role in inflammation associated gastrointestinal malignanciesMolecular profile of colorectal cancer in Indonesia: is there another pathway?Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cellsPhytogenic compounds as alternatives to in-feed antibiotics: potentials and challenges in applicationButyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's diseaseFunctional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cellsSubtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophagesTranscription factor NF kappa B expression and postsurgical organ dysfunctionAberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitisGliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cellsAnti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis ModelParticulate matter air pollution causes oxidant-mediated increase in gut permeability in miceInflammatory bowel diseasePaneth cells as a site of origin for intestinal inflammation.Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes.Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis.Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.Epithelial NF-kappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation.Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patientsGenetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-κB pathway inflammatory responseFarnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer.Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammationTribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signalingEffects of dietary polyphenol-rich plant products from grape or hop on pro-inflammatory gene expression in the intestine, nutrient digestibility and faecal microbiota of weaned pigs.DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic targetThalidomide treatment for refractory Crohn's disease: a review of the history, pharmacological mechanisms and clinical literature.Antisense approach to inflammatory bowel disease: prospects and challenges.Polymorphisms in NF-κB, PXR, LXR, PPARγ and risk of inflammatory bowel diseaseEtiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective.Small therapeutic molecules for the treatment of inflammatory bowel diseaseRecent advances in understanding NF-kappaB regulation.
P2860
Q24669692-EA00F380-83D9-4FE7-98B0-DA39DD112778Q24814806-F8E4BE9B-A5FB-4641-BE12-390CD017BAABQ26772342-64197CAE-E260-4944-A4F5-3017E0C57DB8Q26774688-E5366CF5-36FE-4E1C-B019-A468AF5F5D4CQ26777400-F73D8B38-190A-4BAB-8830-4088C38A9130Q26827637-0F84EC0C-B325-408C-876C-9BFC037CE028Q26865584-F9A929CE-AAEA-40FF-B2D7-37285CBC455EQ27004659-3FA85493-7FA0-49B5-9F31-6B5DF3C16C88Q27021395-0F03280A-8831-4769-B2AE-6AF037CC0E60Q28085601-E3726C12-FD56-4790-A0DA-A7B60240858EQ28143405-244B91B3-7A91-4CFB-B49C-8CB8D64A15B9Q28236807-37EC0EE0-2F6A-4D7E-838D-5DA22C85CABFQ28344913-94A2D3FA-BD14-4CBC-B62C-9FC3B44315EDQ28345627-49721EAE-25A1-4BDA-ACA4-7D916195F5B3Q28472412-A7107594-13D1-4AC8-B30F-18C6324EB59EQ28484010-AF7D8C09-3FF9-4291-A6F6-6C52B5644B99Q28555141-9EF01C11-0DFC-434F-B53A-AE5B463B71C1Q28742767-E9437731-9932-4F9F-9ED0-EA568F1ADB27Q29615500-DB1763FE-A8D9-4D82-98CC-A147490656C1Q30559414-87C68AE9-1C85-441C-A502-FE3F218007C1Q30638019-387EC52E-30E1-4BEA-9C89-CBA2C3032DC7Q30856787-14A33585-B596-4677-A43C-9C8D9AE43806Q32028300-AE6F3058-79B2-4B45-A138-A5721AF98AC9Q33264524-4770E6B3-8143-4363-86F4-4F5659937264Q33556277-C60EEC34-2245-49B8-BA03-27F5AA60D8E3Q33699974-4BFE7804-0F01-4A83-A5BA-014C256F5040Q33881932-A78E325E-731B-492F-8BA5-3FE41E017C11Q34009566-515FC2D7-82A4-4042-B953-9D14700F960AQ34039324-B66CC9E6-3265-4288-800D-3516A98DB992Q34052951-9B5BA861-37AD-4420-94D0-35C1BB82C0E7Q34077080-E30E3877-251A-4153-9770-39B1AD5E99D4Q34136951-C88E222F-D91C-4FDE-BE5D-F75A3A3B83C5Q34151091-1A2EA11A-791A-4075-83BC-90957417DCDFQ34412280-7C855EB4-7832-4BF2-AA9C-E1C2BEE6E469Q34454532-564ECB3E-693A-44CD-B176-555502E4F025Q34473572-D2DC50E3-B288-4367-8C01-0000622FA4BCQ34487187-A5A01210-7A06-47D8-B56C-C6525AF59ECDQ34538014-E38F6A2D-7F10-4F9E-91AC-9D47C83FF363Q34600992-CA17A11C-D9B9-4E6A-94E1-87CF28A78C5CQ34616595-A7BFC0C8-20DE-49BB-A97D-39D2501A9838
P2860
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@en
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@nl
type
label
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@en
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@nl
prefLabel
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@en
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@nl
P2093
P1433
P1476
Nuclear factor kappaB is activ ...... of inflamed intestinal mucosa.
@en
P2093
Baeuerle PA
Hofmeister R
Knuechel R
Schölmerich J
P304
P356
10.1016/S0016-5085(98)70202-1
P407
P577
1998-08-01T00:00:00Z